Economy

Best Hospitals for Thymus Cancer Worldwide

Published

3 years ago

27/04/2023

According to the American Association of Oncologists, thymus cancer is rare and accounts for about 0.5% of all tumors. The illness does not show any signs at the initial stage but, at the same time, has a high potential for malignancy. It is characterized by rapid growth and metastasis.

Over the years, we have accumulated statistics on the leading hospitals in Europe and the US for treating thymus cancer. And we can recommend to patients exactly where they will be treated most effectively. So keep reading, and we will share with you the necessary information.

Criteria for selecting the best hospitals for thymus cancer

Not only an error-free diagnosis and the results of further treatment but sometimes life itself depends on the correct choice of the treatment center and attending physician. Therefore, it is necessary to collect all possible information in order not to be disappointed in the chosen hospital in the future:

Hospitals specialization. It is essential in the treatment of advanced cases of thymus cancer.
It is necessary to look at clinic articles, scientific developments, and the introduction of various treatment methods for thymus cancer.
Information about oncologists and thoracic surgeons who work in this hospital.
It would be good to get acquainted with the reviews of specialists in this field but not working in this clinic.
It is advisable to choose several hospitals and compare them.
The second opinion is an opportunity to verify the accuracy of the diagnosis, to hear an alternative point of view of an experienced specialist, or to learn about alternative treatment options.

Finding a hospital with the online service AiroMedical is fast, simple, and effective. It is enough to specify the doctor’s specialty or the disease’s symptoms in the search bar to find the right specialist. Then, in a few seconds, the system will provide you with a relevant list of the hospitals.

Top hospitals for thymus cancer treatment in the United States

University Hospitals Michigan Ann Arbor

Langone Hospital New York

Wisconsin University Hospitals Madison

Benefits of Medical Treatment in the US

Several essential advantages of the list of hospitals in the US:

Reliable diagnosis, the accuracy of which determines the choice of a treatment plan and the effectiveness of the procedures.
Hybrid operating rooms, the latest microsurgical and minimally invasive operations equipment.
World-class thoracic surgeons who are proficient in all modern methods.

Top hospitals for thymus cancer treatment in Europe

University Hospital Frankfurt, Germany

Marien Hospital Marl, Germany

Teknon Medical Centre, Spain

Anadolu Medical Centre, Turkey

Benefits of medical treatment in Europe

European medicine offers the most current opportunities for timely thymus cancer detection and comprehensive diagnosis. Treatment in hospitals in Europe is also:

World leadership in the number of scientific papers and discoveries in medicine.
Use of unique developments and author’s methods.
Careful monitoring of compliance with international standards at all stages of manipulation.

Top hospitals for thymus cancer treatment in Poland

Medicover Hospital Warsaw

European Health Center Otwock

Gamma Knife Exira Center Katowice

Benefits of medical treatment in Poland

Advantages of Polish cancer treatment:

Fast and accurate examination, low-traumatic technologies.
Complex treatment, including thymus surgery, chemo, and radiotherapy.
Remote consultations with doctors after completion of therapy.

Top hospitals for thymus cancer treatment in Italy

University Hospital San Raffaele Milan

European Oncology Institute Milan

Agostino Gemelli University Policlinic Rome

Benefits of medical treatment in Italy

A whole list of hospitals in Italy has such advantages:

The best doctors with extensive experience treating thymus tumors.
Diagnostics are carried out on innovative equipment that provides 100% accuracy of results.
Healthcare costs are more affordable than in America, and the quality is not inferior.

Top hospitals for thymus cancer treatment in Germany

Helios Clinic Berlin-Buch

University Hospital Charite

University Hospital Heidelberg

Benefits of medical treatment in Germany

Several advantages of hospitals in Germany:

Hybrid operating rooms, robot-assisted surgery.
Close cooperation of German thoracic surgeons with many narrow specialists.
Pediatric thoracic surgeons and oncologists are at the disposal of young patients.

Best thymus cancer doctors worldwide

The best doctors in thymus cancer treatment:

Prof. Dr. med. Maximilian Bockhorn

Dr. med. habil. Krzysztof Wrobel

Prof. Dr. Thomas Vogl

Prof. Dr. Hans Hoffmann

Prof. Dr. Helmut Friess

Best treatment solutions for treating thymus cancer

Doctors of the best hospitals in the US and Europe treat thymus cancer using conservative methods and surgically, taking advantage of the latest oncology achievements that allow achieving success in more than 90% of cases. You can read more about each treatment method for thymus cancer on our website.

Here we will mention only a few:

Da Vinci’s robotic thymectomy. Minimally invasive surgery through four small incisions for the video camera and the robot’s “hands.” The system provides an accurate 3D image of the operating field and the accuracy of movements inaccessible to humans.
Ablation. A needle-like electrode is inserted into the patient, and an electric current is applied. It leads to a local increase in tissue temperature and the destruction of cancer cells.
Brachytherapy. It is the irradiation of the tumor with radioactive isotopes from the inside. Unique seeds with an active substance are injected directly into the cancer tissue with the help of endoscopic equipment.
Targeted therapy. Angiogenesis inhibitors (drugs that prevent the formation of blood vessels) and growth factor inhibitors are most often used.

How to get treatment in the best clinics for thymus cancer

Some diagnoses divide a person’s life into “before” and “after.” You can’t be prepared for them; they sound unfair and scary. Every day in our work, we encounter people tired of endless, fruitless trips to doctors who have almost lost hope of recovery. And how nice it is to see how people’s attitudes to life change after the first positive treatment results.

The AiroMedical project aims to help people who are faced with thymus cancer. On our platform, you will find:

Consultations of leading oncologists, information about the features of diagnosis and thymus cancer treatment.
Hospital contacts and appointments for diagnostics and treatment without queues and tedious waiting.
New therapy methods are used only in a few cancer centers.

Treating thymus cancer with AiroMedical is an opportunity to entrust your health to the best oncologist, constantly improving their professional skills. So leave us a request and get a personalized treatment program.

References

Semenchuk O. Thymus cancer treatment. AiroMedical. Updated January, 2023. https://airomedical.com/search/thymus-cancer-tymoma
Kyiashko D. Thymus cancer guide. AiroMedical. Updated March 22, 2023. https://airomedical.com/blogs/disease-guides/thymus-cancer-guide
Yuan Z., Gao S., Mu J., Xue Q., Mao Y. Long-term outcomes of 307 patients after complete thymoma resection. National library of medicine. Published May 15, 2017. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433013/

Up Next

I’m Not Threatened by Otedola’s Investment in Transcorp—Elumelu

Don't Miss

NASD Securities Market Extends Loss by 0.03%

Dipo Olowookere

Dipo Olowookere is a journalist based in Nigeria that has passion for reporting business news stories. At his leisure time, he watches football and supports 3SC of Ibadan. Mr Olowookere can be reached via [email protected]

1 Comment

Economy

Customs Street Chalks up 1.08% on Renewed Buying Pressure

Published

2 hours ago

06/12/2025

Dipo Olowookere

By Dipo Olowookere

A 1.08 per cent growth was further printed by the Nigerian Exchange (NGX) Limited on Friday on improved appetite for Nigerian stocks.

Data showed that the insurance sector lost 0.61 per cent yesterday due to profit-taking as the energy space gave up 0.08 per cent, while the commodity counter closed flat.

However, the industrial goods landscape appreciated by 2.06 per cent, the banking index improved by 1.31 per cent, and the consumer goods sector expanded by 0.83 per cent.

At the close of business on Customs Street, the All-Share Index (ASI) increased by 1,563.92 points to 147,040.07 points from 145,476.15 points and the market capitalisation went up by N996 billion to N93.722 trillion from N92.726 trillion.

UAC Nigeria led the advancers’ log yesterday after it grew by 10.00 per cent to N96.80, Transcorp Hotels jumped by 9.71 per cent to N172.80, Royal Exchange appreciated by 8.89 per cent to N1.96, Ikeja Hotel soared by 8.74 per cent to N31.10, and Veritas Kapital leapt by 8.07 per cent to N1.74.

On the flip side, Union Dicon declined by 10.00 per cent to N6.30, ABC Transport slipped by 9.88 per cent to N3.10, AXA Mansard depreciated by 7.19 per cent to N12.90, FTN Cocoa lost 4.62 per cent to trade at N4.75, and Guinea Insurance dropped 3.36 per cent to finish at N1.15.

A total of 38 stocks ended on the gainers’ table and 17 stocks finished on the losers’ table, representing a positive market breadth index and strong investor sentiment.

Traders transacted 361.6 million equities for N14.8 billion in 21,051 deals yesterday versus the 1.9 billion equities worth N19.2 billion traded in 23,369 deals a day earlier, showing a decline in the trading volume, value, and number of deals by 80.97 per cent, 22.92 per cent, and 14.20 per cent, respectively.

The busiest stock for the session was Zenith Bank with 59.5 million units worth N3.6 billion, Access Holdings traded 46.1 million units valued at N973.0 million, Fidelity Bank exchanged 29.4 million units for N560.4 million, FCMB transacted 27.9 million units worth N293.9 million, and Tantalizers sold 13.0 million units valued at N29.8 million.

Economy

Nipco, 11 Plc Crash OTC Securities Exchange by 4.76%

Published

3 hours ago

06/12/2025

Adedapo Adesanya

By Adedapo Adesanya

Energy stocks influenced the 4.76 per cent loss recorded by the NASD Over-the-Counter (OTC) Securities Exchange on Friday, December 5.

The culprits were the duo of 11 Plc and Nipco Plc,with the former shedding N32.17 to end at N291.83 per share compared with the previous day’s N324.00 per share, and the latter down by N21.00 to sell at N195.00 per unit versus the previous session’s N216.00 per unit.

Consequently, the NASD Unlisted Security Index (NSI) slumped by 170.16 points to 3,401.37 points from 3,571.53 points and the market capitalisation lost N101.81 billion to close at N2.035 billion from the N2.136 trillion quoted in the preceding session.

The OTC securities exchange suffered the decline yesterday despite the share prices of three companies closing green.

Central Securities Clearing System (CSCS) Plc was up by N1.80 to close at N39.80 per share compared with Thursday’s price of N38.00 per share, Air Liquide Plc appreciated by N1.09 to N11.99 per unit from N10.90 per unit, and FrieslandCampina Wamco Nigeria Plc grew by 78 Kobo to N56.57 per share from N55.79 per share.

During the session, the volume of transactions rose by 6,885.3 per cent to 18.2 million units from 4.3 million units, the value of transactions ballooned by 10,301.7 per cent to N389.7 million from N347.2 million, but the number of deals declined by 29.7 per cent to 26 deals from 37 deals.

Infrastructure Credit Guarantee Company (InfraCredit) Plc ended the day as the most traded stock by value on a year-to-date basis with 5.8 billion units worth N16.4 billion, followed by Okitipupa Plc with 170.4 million units valued at N8.0 billion, and Air Liquide Plc with 507.5 million units worth N4.2 billion.

InfraCredit Plc also finished the day as the most traded stock by volume on a year-to-date basis with 5.8 billion units transacted for N16.4 billion, followed by Industrial and General Insurance (IGI) Plc with 1.2 billion units sold for N420.2 million, and Impresit Bakolori Plc with 536.9 million units worth N524.9 million.

Economy

Naira Depreciates to N1,450/$1 at Official Forex Market

Published

3 hours ago

06/12/2025

Adedapo Adesanya

By Adedapo Adesanya

The Naira depreciated further against the US Dollar in the Nigerian Autonomous Foreign Exchange Market (NAFEX) on Friday, December 5, as FX demand pressure mounts.

The Nigerian currency lost N2.60 or 0.18 per cent against the greenback to close at N1,450.43/$1 compared with the previous day’s N1,447.83/$1.

Equally, the domestic currency declined against the Pound Sterling in the official forex market during the session by N4.48 to trade at N1,935.45/£1, in contrast to Thursday’s closing price of N1,930.97/£1 and shrank against the Euro by 43 Kobo to end at N1,689.17/€1 versus the preceding session’s rate of N1,688.74/€1.

Similarly, the local currency performed badly against the US Dollar at the GTBank FX counter by N2 to close at N1,455/$1 versus Thursday’s N1,453/$1 but traded flat at the parallel market at N14.65/$1.

As the country gets into the festive period, pressure mounted on the local currency reflecting higher foreign payments and lower FX inflows.

However, there are expectations that the Nigerian currency will be stable, supported by interventions by to the Central Bank of Nigeria (CBN) in the face of steady dollar Demand and inflows from Detty December festivities that will give the Naira a boost after it depreciated mildly last month.

Traders cited by Reuters expect that the Naira will trade within a band of N1,443-N1,450/$1 next week, buoyed by improved FX interventions by the apex bank.

As for the crypto market, it was down yesterday due to profit-taking associated with year-end trading. However, the December 1-Year Consumer Inflation Expectation by the University of Michigan fell to 4.1 per cent from 4.5 per cent previously and 4.5 per cent expected. The 5-Year Consumer Inflation Expectation fell to 3.2 per cent from 3.4 per cent previously and 3.4 per cent expected.

With the dearth of official economic data of late, these private surveys have taken on a new level of significance and the market banks of them to make decisions.

Cardano (ADA) depreciated by 5.7 per cent to $0.4142, Dogecoin (DOGE) slid by 5.1 per cent to $0.1394, Ethereum (ETH) dropped by 3.9 per cent to $3,039.75, Solana (SOL) declined by 3.8 per cent to $133.24, and Litecoin (LTC) fell by 3.7 per cent to $80.59.

Further, Bitcoin (BTC) went down by 2.6 per cent to sell at $89,683.72, Binance Coin (BNB) slumped by 2.2 per cent to $883.59, and Ripple (XRP) shrank by 2.1 per cent to $2.04, while the US Dollar Tether (USDT) and the US Dollar Coin (USDC) remained unchanged at $1.00 each.